Nat Rev Drug Discov. 2008 Aug;7(8):678-93.

Targeting bile-acid signalling for metabolic diseases.

Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K.

Source

Institute of Genetics and Molecular and Cellular Biology, 1 Rue Laurent Fries, 67404 Illkirch, France.

Abstract

Bile acids are increasingly being appreciated as complex metabolic integrators and signalling factors and not just as lipid solubilizers and simple regulators of bile-acid homeostasis. It is therefore not surprising that a number of bile-acid-activated signalling pathways have become attractive therapeutic targets for metabolic disorders. Here, we review how the signalling functions of bile acids can be exploited in the development of drugs for obesity, type 2 diabetes, hypertriglyceridaemia and atherosclerosis, as well as other associated chronic diseases such as non-alcoholic steatohepatitis.

PMID:: 18670431; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Bile Acids and Salts

LinkOut - more resources

Full Text Sources

Medical

Metabolic Disorders - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders. [Drug Discov Today. 2009]
Review TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders.
Tiwari A, Maiti P. Drug Discov Today. 2009 May; 14(9-10):523-30. Epub 2009 Feb 25.
Review Targeting farnesoid X receptor for liver and metabolic disorders. [Trends Mol Med. 2007]
Review Targeting farnesoid X receptor for liver and metabolic disorders.
Fiorucci S, Rizzo G, Donini A, Distrutti E, Santucci L. Trends Mol Med. 2007 Jul; 13(7):298-309. Epub 2007 Jun 27.
Review Endocrine functions of bile acids. [EMBO J. 2006]
Review Endocrine functions of bile acids.
Houten SM, Watanabe M, Auwerx J. EMBO J. 2006 Apr 5; 25(7):1419-25. Epub 2006 Mar 16.
Review Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. [Nat Rev Drug Discov. 2008]
Review Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.
Furuhashi M, Hotamisligil GS. Nat Rev Drug Discov. 2008 Jun; 7(6):489-503.
Review FXR signaling in metabolic disease. [FEBS Lett. 2008]
Review FXR signaling in metabolic disease.
Zhang Y, Edwards PA. FEBS Lett. 2008 Jan 9; 582(1):10-8. Epub 2007 Nov 20.

See reviews... See all...

Cited by 37 PubMed Central articles

Cellular mechanism of bile acid-accelerated hepatocyte polarity. [Small Gtpases. 2011]
Cellular mechanism of bile acid-accelerated hepatocyte polarity.
Fu D, Lippincott-Schwartz J, Arias IM. Small Gtpases. 2011 Nov 1; 2(6):314-317.
Nuclear receptor variants in liver disease. [J Lipids. 2012]
Nuclear receptor variants in liver disease.
Müllenbach R, Weber SN, Lammert F. J Lipids. 2012; 2012:934707. Epub 2011 Dec 21.
Interspecies Chemical Signals Released into the Environment May Create Xenohormetic, Hormetic and Cytostatic Selective Forces that Drive the Ecosystemic Evolution of Longevity Regulation Mechanisms. [Dose Response. 2012]
Interspecies Chemical Signals Released into the Environment May Create Xenohormetic, Hormetic and Cytostatic Selective Forces that Drive the Ecosystemic Evolution of Longevity Regulation Mechanisms.
Burstein MT, Beach A, Richard VR, Koupaki O, Gomez-Perez A, Goldberg AA, Kyryakov P, Bourque SD, Glebov A, Titorenko VI. Dose Response. 2012; 10(1):75-82. Epub 2011 Jul 27.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioSystems
Pathways and biological systems (BioSystems) that cite the current articles. Citations are from the BioSystems source databases (KEGG and BioCyc).
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Targeting bile-acid signalling for metabolic diseases.
Targeting bile-acid signalling for metabolic diseases.
Nat Rev Drug Discov. 2008 Aug ;7(8):678-93.

PubMed
[The differentiation of intestinal Escherichia coli infections].
[The differentiation of intestinal Escherichia coli infections].
Zh Mikrobiol Epidemiol Immunobiol. 1991 Feb ;(2):81-7.

PubMed
Left ventricular longitudinal systolic dysfunction is an independent marker of c...
Left ventricular longitudinal systolic dysfunction is an independent marker of cardiovascular risk in patients with hypertension.
Am J Hypertens. 2008 Sep ;21(9):1047-54. Epub 2008 Jul 31 .

PubMed
Hydroxysafflor yellow A enhances survival of vascular endothelial cells under hy...
Hydroxysafflor yellow A enhances survival of vascular endothelial cells under hypoxia via upregulation of the HIF-1 alpha-VEGF pathway and regulation of Bcl-2/Bax.
J Cardiovasc Pharmacol. 2008 Aug ;52(2):191-202.

PubMed
Prostatic biology, histologic patterns and clinical consequences of transitional...
Prostatic biology, histologic patterns and clinical consequences of transitional cell carcinoma.
Curr Opin Urol. 2008 Sep ;18(5):508-12.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: